Cargando…

Malignant hyperthermia testing in probands with NO adverse anesthetic reaction

Detalles Bibliográficos
Autores principales:	Sterling, Carly, Rosenberg, Henry, Kraeva, Natalia, Riazi, Sheila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139667/ http://dx.doi.org/10.1186/1471-2253-14-S1-A2

Ejemplares similares

Accuracy of the diagnosis of malignant hyperthermia in hospital discharge records
por: Pinyavat, Teeda, et al.
Publicado: (2014)

Malignant hyperthermia mutations and correlation with the severity of the anesthetic complication and the level of the in vitro contracture tests
por: Krivosic-Horber, René, et al.
Publicado: (2014)

Development and evolution of the MHAUS cognitive aid for malignant hyperthermia
por: Pinyavat, Teeda, et al.
Publicado: (2014)

French guidelines for the management of malignant hyperthermia
por: Krivosic-Horber, René
Publicado: (2014)

Analysis of malignant hyperthermia results in Padua and Siena
por: Tegazzin, Vincenzo, et al.
Publicado: (2014)

Malignant hyperthermia on ICU – sudden attack of the “snake”
por: Johannsen, Stephan, et al.
Publicado: (2014)

Carnitine palmitoyltransferase 2 deficiency, malignant hyperthermia and anesthesia
por: Glauber, Violeta, et al.
Publicado: (2014)

Dantrolene in the treatment of malignant hyperthermia: a case report
por: Islander, Gunilla
Publicado: (2014)

Gene expression in the context of malignant hyperthermia status and ageing
por: Baines, Kathie Nicoll, et al.
Publicado: (2014)

Malignant hyperthermia as a rare cause of SIRS after cardiac surgery
por: Theuerkauf, Nils, et al.
Publicado: (2014)

Knowledge on malignant hyperthermia: as rare as the disease? A nation wide survey
por: Wolvetang, Timothy, et al.
Publicado: (2014)

Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility
por: Fiszer, Dorota, et al.
Publicado: (2014)

Preferential allele amplification leading to RyR1 misgenotyping in a malignant hyperthermia susceptible individual
por: Gonzalez, Asensio, et al.
Publicado: (2014)

Update of the quality assurance (QA) results of halothane and caffeine analysis of all current participating malignant hyperthermia units
por: Fisher, Nickla, et al.
Publicado: (2014)

Exome analysis identifies Brody myopathy in a family diagnosed with malignant hyperthermia susceptibility
por: Sambuughin, Nyamkhishig, et al.
Publicado: (2014)

Variants in ASPH cause exertional heat illness and are associated with malignant hyperthermia susceptibility
por: Endo, Yukari, et al.
Publicado: (2022)

Cutaneous adverse drug reactions induced by Oxcarbazepine
por: Hsiao, Yi-Hsin, et al.
Publicado: (2014)

Malignant hyperthermia
por: Rosenberg, Henry, et al.
Publicado: (2007)

Effects of Theophylline on Anesthetized Malignant Hyperthermia-Susceptible Pigs
por: Fiege, Marko, et al.
Publicado: (2011)

Profilin desensitisation in patients with adverse reaction after plant-derived: our experience
por: Mezzacappa, Simona, et al.
Publicado: (2015)

Malignant hyperthermia: a review
por: Rosenberg, Henry, et al.
Publicado: (2015)

Intra-operative post-induction hyperthermia, possibly malignant hyperthermia: Anesthetic implications, challenges and management
por: Gulabani, Michell, et al.
Publicado: (2014)

Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients
por: Valeyrie-Allanore, Laurence, et al.
Publicado: (2014)

A prospective study of HLA*B-5801 genotyping in preventing allopurinol- induced severe cutaneous adverse reactions
por: Ko, Tai-Ming, et al.
Publicado: (2014)

Highlights of the 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, London, November 2010
por: Schambelan, M
Publicado: (2010)

Intraoperative tachycardia, hypercapnia, hyperthermia and muscle stiffness in a dantrolene unavailability case. Can calcium channel blockers be valuable?
por: Marques, Acílio, et al.
Publicado: (2014)

Development of a malignant hyperthermia protocol
por: Yeung, EYH, et al.
Publicado: (2015)

Overlap between maculopapular exanthema and DRESS among cutaneous adverse drug reactions in a dermatology ward (2008-2012)
por: Gouveia, Miguel Pinto, et al.
Publicado: (2014)

Implementation of sonication and feedback control strategies for targeted hyperthermia in prostate with a commercial MR-guided endorectal ultrasound ablation array
por: Salgaonkar, Vasant, et al.
Publicado: (2015)

Variant Curation Expert Panel Recommendations for RYR1 Pathogenicity Classifications in Malignant Hyperthermia Susceptibility
por: Johnston, Jennifer J., et al.
Publicado: (2021)

100 telephone conversations about malignant hyperthermia
por: Petersen, Bodil, et al.
Publicado: (2014)

The child’s immune system and pediatric tuberculosis
por: Bellanti, Joseph A, et al.
Publicado: (2010)

Malignant hyperthermia and beyond - a virtual BioBank
por: Underwood, Rosie, et al.
Publicado: (2014)

fMRI correlates for low frequency local field potentials appear as a spatiotemporal dynamic under multiple anesthetic conditions
por: Thompson, Garth J, et al.
Publicado: (2012)

Sleep disruption and adverse pregnancy outcomes
por: O’Brien, Louise M
Publicado: (2012)

The couplonopathies: A comparative approach to a class of diseases of skeletal and cardiac muscle
por: Ríos, Eduardo, et al.
Publicado: (2015)

Adverse effects of rheumatoid arthritis on bone remodeling
por: Goldring, SR, et al.
Publicado: (2004)

Predictors of in-hospital adverse outcomes in aortic surgery
por: Sales, M, et al.
Publicado: (2013)

Healthcare professionals, substance use and adverse childhood experiences
por: Baklazec, Agnieszka, et al.
Publicado: (2015)

Basophil activation test is food adverse reactions
por: Pignatti, Patrizia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_23t64nfpmo8mh8i5rditi6p77j